Bryan P. Schneider, MD, recipient of the 2012 Young Investigator Award, has been invited to discuss his research on breast cancer biomarkers at the Fall 2012 Group Meeting as part of the recognition associated with the award. Dr. Schneider’s presentation, Breast Cancer Genomics and Pharmacogenomics: Making it Personal, will be the keynote address at the General Session, which will be held on Saturday, November 10 from 6:30 to 8:00 PM in the Grand East Ballroom at The Westin Diplomat Resort & Spa in Hollywood, FL. A reception for all in attendance will follow the General Session.
Group meetings are closed to the public; however, each Group meeting includes a General Session that is open to industry and other interested external representatives. The General Session is the highlight of the meeting—a time when all in attendance come together to hear Group-wide news and announcements and enjoy special presentations on relevant topics.
Dr. Schneider is an Associate Professor of Medicine in the Department of Medicine, the Division of Hematology/Oncology and Clinical Pharmacology, and the Department of Medical and Molecular Genetics at the Indiana University School of Medicine and a researcher at the Indiana University Melvin and Bren Simon Cancer Center (Indianapolis, IN). He joined ECOG in 2007. He is a member of the Breast Committee and also the Developmental Therapeutics Committee, where he serves as Vice Chair of the Pharmacogenetics Sub-Committee. In 2010, he chaired ECOG’s Education Symposium for Developmental Therapeutics and led the Survivorship Working Group.
Read the press release
ECOG-ACRIN Young Investigator Symposium Awards
Joseph A. Sparano, MD
This year, eight young investigators have been invited to give oral presentations of their research at the Group meeting as part of the Young Investigator Symposium. The Symposium will take place on Friday, November 9 from 1:00 to 3:00 PM in Room 307.
It is a tradition to honor two of the presenters with awards of distinction—one award in the clinical research category, and the other in the translational research category. Dr. Sparano, Program Chair, will announce this year’s recipients and provide a recap of the Symposium.
Making the Informed Consent Document More Concise: Revising the NCI Consent Form Template
Jeanne M. Adler, RN, MPH
There is concern that the balance in consent forms has tipped in favor of comprehensiveness instead of comprehension. Consent forms for cancer clinical trials are often lengthy and may be written at a level that is too complex for many patients to understand, particularly those who are stressed by a new diagnosis or the identification of disease progression, or who may have limited health literacy or English comprehension. This presentation will describe actions taken by the National Cancer Institute (NCI) to address consent form problems, including revising the NCI consent form template to achieve a more concise document that still accurately captures the required elements of informed consent. Ms. Adler is Head of Central Institution Review Board Strategy and Operations at the NCI.
For more information, see the full agenda posted on the Group Meeting website.